Oramed Pharmaceuticals Inc. (ORMP): Price and Financial Metrics

Oramed Pharmaceuticals Inc. (ORMP)

Today's Latest Price: $5.08 USD

0.10 (-1.93%)

Updated Jan 24 12:00am

Add ORMP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all "A" rated Strong Buy stocks

ORMP Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ORMP is 0.16 -- better than only 12.72% of US stocks.
  • For ORMP, its debt to operating expenses ratio is greater than that reported by merely 8.16% of US equities we're observing.
  • ORMP's price/sales ratio is 33.86; that's higher than the P/S ratio of 95.95% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Oramed Pharmaceuticals Inc are KALV, CNAT, RCUS, VNE, and MGEN.
  • ORMP's SEC filings can be seen here. And to visit Oramed Pharmaceuticals Inc's official web site, go to www.oramed.com.
ORMP Daily Price Range
ORMP 52-Week Price Range

ORMP Stock Price Chart More Charts

ORMP Price/Volume Stats

Current price $5.08 52-week high $6.05
Prev. close $5.18 52-week low $2.32
Day low $5.01 Volume 88,100
Day high $5.29 Avg. volume 136,025
50-day MA $4.56 Dividend yield N/A
200-day MA $3.65 Market Cap 90.10M

Oramed Pharmaceuticals Inc. (ORMP) Company Bio

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company was founded in 2002 and is based in Jerusalem, Israel.

ORMP Latest News Stream

Event/Time News Detail
Loading, please wait...

ORMP Latest Social Stream

Loading social stream, please wait...

View Full ORMP Social Stream

ORMP Price Returns

1-mo -3.79%
3-mo 60.76%
6-mo 37.30%
1-year 45.98%
3-year -19.87%
5-year 3.25%
YTD -1.36%
2019 71.67%
2018 -66.67%
2017 47.06%
2016 -28.42%
2015 87.50%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.511 seconds.